Michelhaugh, S., Kiousis, S., Klinger, N., & Mittal, S. (2018). RDNA-07. IDH1-MUTANT GLIOBLASTOMA (GBM) CELLS FROM A PATIENT POST-TUMOR TREATING FIELDS (TTFIELDS) THERAPY ARE SENSITIVE TO TTFIELDS IN VITRO. Neuro Oncol.
Citação norma ChicagoMichelhaugh, Sharon, Sam Kiousis, Neil Klinger, and Sandeep Mittal. "RDNA-07. IDH1-MUTANT GLIOBLASTOMA (GBM) CELLS FROM A PATIENT POST-TUMOR TREATING FIELDS (TTFIELDS) THERAPY ARE SENSITIVE TO TTFIELDS IN VITRO." Neuro Oncol 2018.
Citação norma MLAMichelhaugh, Sharon, Sam Kiousis, Neil Klinger, and Sandeep Mittal. "RDNA-07. IDH1-MUTANT GLIOBLASTOMA (GBM) CELLS FROM A PATIENT POST-TUMOR TREATING FIELDS (TTFIELDS) THERAPY ARE SENSITIVE TO TTFIELDS IN VITRO." Neuro Oncol 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.